Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4285090
Max Phase: Preclinical
Molecular Formula: C29H45N6O9P
Molecular Weight: 652.69
Molecule Type: Small molecule
Associated Items:
ID: ALA4285090
Max Phase: Preclinical
Molecular Formula: C29H45N6O9P
Molecular Weight: 652.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O
Standard InChI: InChI=1S/C29H45N6O9P/c1-20(44-45(41,42)43)26(27(30)38)34-29(40)25(18-36)33-28(39)24(32-21(2)37)16-23-17-31-19-35(23)15-11-6-4-3-5-8-12-22-13-9-7-10-14-22/h7,9-10,13-14,17,19-20,24-26,36H,3-6,8,11-12,15-16,18H2,1-2H3,(H2,30,38)(H,32,37)(H,33,39)(H,34,40)(H2,41,42,43)/t20-,24+,25+,26+/m1/s1
Standard InChI Key: RLKOZTUQTILVBD-CHQQOIJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 652.69 | Molecular Weight (Monoisotopic): 652.2986 | AlogP: 0.46 | #Rotatable Bonds: 21 |
Polar Surface Area: 235.20 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.35 | CX Basic pKa: 6.51 | CX LogP: -2.06 | CX LogD: -3.64 |
Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.07 | Np Likeness Score: -0.03 |
1. Hymel D, Grant RA, Tsuji K, Yaffe MB, Burke TR.. (2018) Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors., 28 (19): [PMID:30174151] [10.1016/j.bmcl.2018.08.018] |
Source(1):